SDA HOLDING
Board
3 directors, last change in 2025Aubisque BV
Director, permanent representative Freya Loncin
since 13-09-2023
term for the life of the company
listed in the 2025 annual accounts, filed on 13-08-2026
1 other company bankruptJuleste Consulting BV
Director, permanent representative Nathalie Baert
since 13-09-2023
term for the life of the company
listed in the 2025 annual accounts, filed on 13-08-2026
BVJS BV
Director, permanent representative Ben Jansen
since 25-06-2024
term for the life of the company
listed in the 2025 annual accounts, filed on 13-08-2026
BLUEBOLD
Director (executive), permanent representative Benoit BRONCKART
appointed by deed of 18-10-2023
Permanent representatives 4
Mandates through the years
10 names, the dashed line is todayAubisque BV
Director
Director
Juleste Consulting BV
Director
Director
BVJS BV
Director
Director
BLUEBOLD
Director (executive)
Director (executive)
Idea4Business BV
Director
Director
ALYCHLO
Director
Director
CRESCEMUS B.V.
Director
Director
Dovil SPRL
Director
Director
Nicole de Dobbelaere
Director
Director
Bart Maerten
Managing director
Managing director
BoardOther functionEarliermandate already running before its first mentionend not dated
Mandates as a list
- Aubisque BV
- Director, from 13-09-2023 to date
- Juleste Consulting BV
- Director, from 13-09-2023 to date
- BVJS BV
- Director, from 25-06-2024 to date
- BLUEBOLD
- Director (executive), appointed by deed of 18-10-2023, still in office
- Idea4Business BV
- Director, appointed by deed of 18-10-2023, until 25-06-2024
- ALYCHLO
- Director, from before 05-05-2021 to 13-09-2023
- CRESCEMUS B.V.
- Director, from before 05-05-2021 to 13-09-2023
- Dovil SPRL
- Director, appointed by deed of 15-05-2019, until 13-09-2023
- Managing director, appointed by deed of 15-05-2019, last mentioned in 2019
- Nicole de Dobbelaere
- Director, from before 05-05-2021 to 13-09-2023
- Bart Maerten
- Director, until 20-12-2018
- Managing director, until 20-12-2018
Control
81.7%
This company
SDA HOLDING
Equity €19.0m
Profit €1.5m in 2025
Further up the chainALYCHLO 98.79%
Capital
- Capital
- €14,787,000
- Source
- deed of 28-09-2023
Owners through the years
as the annual accounts name themOwners as a list
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 01-08-2023 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsTerm of at most 6 years“6 ans, assemblée générale”deed of 01-08-2023 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Wednesday of May at 09:00deed of 26-01-2018 (in French)
Shareholders
2 ownersOwners 2
- SDA GroupparentEquity €52.0m Loss of €3,843 in 2025 (loss of €6,685 in 2024)Sourceaccounts SDA Group 202581.7%
- Equity €965.2m Profit of €32.9m in 2025 (profit of €40.2m in 2024)Sourceaccounts ALYCHLO 202518.31%
Capital transactions
Capital over time
- 28-09-2023 Capital increase of €6,000,000 · to €14,787,000 · 19,950 new shares
- 01-08-2023 Capital reduction of €115,000 · to €8,787,000 · repaid to the shareholders
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck offAubisque BV
1 other company of this director went bankrupt (2024).
- Mithra Pharmaceuticals bankruptcy on 10-06-2024Official Gazettemandate until 2021
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.